Total Payments
$325.54
2024 Payments
$102.51
Companies
10
Transactions
19
Medicare Patients
1,888
Medicare Billing
$140,058
Payment Breakdown by Category
Food & Beverage$325.54 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $325.54 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $114.55 | 7 | $0 (2024) |
| PFIZER INC. | $37.56 | 2 | $0 (2024) |
| Abbott Laboratories | $36.59 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $26.45 | 2 | $0 (2022) |
| Exact Sciences Corporation | $24.38 | 1 | $0 (2024) |
| Antares Pharma, Inc. | $19.63 | 1 | $0 (2024) |
| Novo Nordisk Inc | $19.22 | 1 | $0 (2022) |
| Axsome Therapeutics, Inc. | $17.61 | 1 | $0 (2024) |
| Dexcom, Inc. | $16.89 | 1 | $0 (2023) |
| Lilly USA, LLC | $12.66 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102.51 | 5 | Exact Sciences Corporation ($24.38) |
| 2023 | $34.82 | 2 | ABBVIE INC. ($17.93) |
| 2022 | $106.35 | 7 | ABBVIE INC. ($48.02) |
| 2021 | $81.86 | 5 | Abbott Laboratories ($36.59) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/06/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/11/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Endocrinology | ||||||
| 08/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.50 | General |
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.95 | General |
| 05/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
| 03/23/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/16/2022 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Diabetes | ||||||
| 07/15/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes Care | ||||||
| 06/02/2021 | Abbott Laboratories | Proclaim IPG (Device) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Neuromodulation | ||||||
| 05/20/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: GASTROINTESTINAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 367 | 669 | $67,241 | $30,741 |
| 2022 | 12 | 494 | 908 | $81,233 | $36,953 |
| 2021 | 10 | 511 | 884 | $76,184 | $37,291 |
| 2020 | 11 | 516 | 879 | $78,205 | $35,073 |
Total Patients
1,888
Total Services
3,340
Medicare Billing
$140,058
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 120 | 324 | $33,696 | $14,666 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 164 | $25,256 | $10,909 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $6,105 | $3,669 | 60.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 20 | 21 | $630.00 | $617.40 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 21 | $336.00 | $329.28 | 98.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 20 | $680.00 | $324.40 | 47.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 18 | $216.00 | $151.20 | 70.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 20 | 23 | $322.00 | $73.83 | 22.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 38 | 41 | $0.41 | $0.34 | 82.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 142 | 448 | $46,592 | $20,531 | 44.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 127 | $19,558 | $8,426 | 43.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 51 | 51 | $8,415 | $5,315 | 63.2% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 22 | 23 | $690.00 | $675.17 | 97.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,848 | $500.24 | 27.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 12 | 12 | $936.00 | $495.73 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 22 | 23 | $368.00 | $360.96 | 98.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 32 | $1,120 | $235.10 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 44 | 64 | $768.00 | $190.11 | 24.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 26 | 34 | $476.00 | $116.87 | 24.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 27 | 33 | $462.00 | $106.90 | 23.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 49 | 49 | $0.49 | $0.34 | 69.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 145 | 408 | $42,432 | $19,919 | 46.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 121 | $18,634 | $8,404 | 45.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $10,560 | $6,814 | 64.5% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 31 | 31 | $930.00 | $878.80 | 94.5% |
About Johanna Weir, PA-C
Johanna Weir, PA-C is a Medical healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740499730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Johanna Weir, PA-C has received a total of $325.54 in payments from pharmaceutical and medical device companies, with $102.51 received in 2024. These payments were reported across 19 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($325.54).
As a Medicare-enrolled provider, Weir has provided services to 1,888 Medicare beneficiaries, totaling 3,340 services with total Medicare billing of $140,058. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Bartlesville, OK
- Active Since 05/22/2007
- Last Updated 01/14/2015
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1740499730
Products in Payments
- VRAYLAR (Drug) $114.55
- Cologuard Collection Kit (Device) $24.38
- Proclaim IPG (Device) $20.81
- COLOGUARD DNA CAPTURE REAGENTS (Device) $19.88
- XYOSTED (Drug) $19.63
- Rybelsus (Drug) $19.22
- ELIQUIS (Drug) $17.68
- Auvelity (Drug) $17.61
- Dexcom G6 Transmitter (Medical Supply) $16.89
- FreeStyle Libre 2 (Device) $15.78
- TRULICITY (Drug) $12.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.